<?xml version="1.0" encoding="UTF-8"?>
<ref id="B94-vaccines-07-00203">
 <label>94.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dejnirattisai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wongwiwat</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Supasa</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Dai</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Rouvinsky</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jumnainsong</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Edwards</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Quyen</surname>
    <given-names>N.T.H.</given-names>
   </name>
   <name>
    <surname>Duangchinda</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus</article-title>
  <source>Nat. Immunol.</source>
  <year>2014</year>
  <volume>16</volume>
  <fpage>170</fpage>
  <lpage>177</lpage>
  <pub-id pub-id-type="doi">10.1038/ni.3058</pub-id>
  <pub-id pub-id-type="pmid">25501631</pub-id>
 </element-citation>
</ref>
